Synopsis Perindopril is a long acting angiotensin converting enzyme (ACE) inhibitor, which
displays similar pharmacodynamic properties to other agents in this class. In common with …

Available information indicates that about 78 new molecules belonging to the class of
angiotensin converting enzyme (ACE) inhibitors are under investigation, and that at least 11 …

We profiled the concentrations of angiotensin I (Ang I), angiotensin II (Ang II), and
angiotensin (1–7)[Ang (1–7)] by the combination of radioimmunoassay and high …

Current leading theories of the mechanisms of essential hypertension include the
participation of the renin-angiotensin-aldosterone system (RAS). Recent advances provide …

The physiological effects of angiotensin-converting enzyme (ACE) inhibition may be in part
mediated by bradykinin. We investigated the effect of coadministration of the specific …

Objective We reviewed the evidence for an intrinsic ovarian renin-angiotensin system
(OVRAS), highlighting potential diverse signaling in this system through different bioactive …

In the present study, we evaluated the hemodynamic and metabolic profiles derived from
oral administration of the angiotensin converting enzyme inhibitor, delapril 50 mg/kg/day …

This study demonstrates that a novel angiotensin I analog, angiotensinogen 3–11 (Lys11),
possesses a high affinity for angiotensin-converting enzyme (ACE), which is substantially …

The effect of enalapril, an angiotensin converting enzyme inhibitor, on glucose tolerance
and serum insulin response to a glucose load has been evaluated in 8 non-obese patients …

We studied the plasma renin activity (PRA) and blood pressure (BP) responses to a single
oral dose of captopril in children with renal scarring due to vesicoureteral reflux. The test …